News

Sort news by
01/21/2015 - 3:15pm

Several scientists have published the results of important DM research. Dr. Katharine Hagerman, PhD, Research Assistant at Stanford University, has provided MDF with lay summaries of some of this research.

01/07/2015 - 3:39pm

The MDF Fund-a-Fellow program is designed to help attract new researchers to the DM field, increasing the knowledge and science available regarding myotonic dystrophy. We are pleased to announce this year’s award recipients!

12/11/2014 - 9:31am

Isis Pharmaceuticals, Inc. has initiated a Phase I/II trial for ISIS-DMPKrx in patients affected by myotonic dystrophy type 1 (DM1).

12/10/2014 - 2:18pm

In 2013, MDF launched a significant effort to increase the number of support groups for families living with DM, and we now have 14 groups across the US and Canada. Join us in celebrating the people who have brought these groups to life!

12/09/2014 - 3:36pm

Dr. Tetsuo Ashizawa, MD, has focused his career on the search for DM treatments and care for those affected. His multi-disciplinary, patient-centric approach to care moves DM research out of the lab and into his clinic at the University of Florida.

Pages